In 2016, the Older People’s Mental Health Service (OPMHS) within Bedfordshire and Luton (provided by East London Foundation National Health Service Trust) faced considerable challenges in providing an accessible service for assessment of suspected dementia. Those referred to the Memory Assessment Service (MAS) encountered waiting times exceeding national recommendations. A quality improvement (QI) project was initiated by OPMHS Psychologists within all four multidisciplinary MAS clinics in Bedfordshire and Luton. The project aimed to reduce the time from the date of referral for within-team neuropsychological assessment to finalisation of the report to 6 weeks (42 days) by April 2017. In parallel to the initiative, the wider impact of the QI project was investigated. Through the combination of change ideas tested and implemented, all four MAS clinics were successful in meeting the primary project aim. The combined mean time between referral received by psychology and report finalised reduced by 28.76 days from 65.1 to 36.34 days, and with reduced variation across the clinics. These changes were sustained throughout the duration of the project and beyond, and successful change ideas were incorporated into routine practice with control methods developed. Exploring the wider impact, a focus group with six psychology staff members involved in the project was also completed. Thematic analysis identified three themes from the focus group: staff impact, service impact and service user impact. Further subthemes were identified regarding both desirable and undesirable impact across the system. The approaches used may be useful for other services embarking on reduced wait time initiatives for access to care. Additionally, understanding ongoing areas of impact on staff, the wider service and service users can help reduce or mitigate undesirable or unintended consequences and work towards sustainability of such changes.
Objective Little has been published about maternity outcomes from New Zealand’s unique handling of the COVID-19 pandemic. Objectives were to determine obstetric outcomes between the variants, identify risk factors, and whether the changes to healthcare delivery affected pregnancy outcomes. Design This was a case control study comparing singleton pregnancies affected by the Delta and Omicron strains of COVID-19. The COVID 19-free controls were from 2019. Setting & Population The largest tertiary maternity unit in New Zealand providing taxpayer funded healthcare to a multi-ethnic, high deprivation index population with complex health needs. Methods Data were extracted from electronic record systems and further verified by reviewing patient’s notes. The risk of an event was modelled with logistic regression. The multivariate analyses adjusted for known clinical risk factors and other significant differences between the groups. Main Outcome Measures Outcomes of interest included admission for COVID-19, adverse pregnancy outcomes, including placentally-mediated ones. Results In the study population of > 8,000 pregnancies, Delta variant was associated with significantly worse maternal and obstetric outcomes. Fetal anomalies and most placentally-mediated adverse outcomes of pregnancy in the COVID-19 affected cohort did not persist once adjusted for underlying maternal risk factors, except for a 4-fold increased risk of stillbirth. Vaccination was protective against admissions and severe disease (OR 0.19;95%CI 0.11-0.32). Conclusions While the Delta variant has been associated with poorer outcomes, modifications to the delivery of maternity care during the pandemic could have unintended consequences on how patients utilised healthcare; this may have contributed to poorer outcomes.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.